Delivery Order SPE2DB20D7059-SPE2DB24FQAT5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Levothyroxine 150 MCG tablets. The delivery order has a firm fixed price of $2,304.88 and a period of performance through March 13, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this award. It is also the prime contractor on a larger $999,999,999 indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,203,393 units of levothyroxine 100 mcg/5 ml in 5 ml vials. The completion date for this $3,662.25 contract is January 2, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA to supply pharmaceuticals, medical supplies, and distribution...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 137 MCG Tablets in 1,000-count quantities, with a ceiling value of $1,617.60 and a performance period through October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,806,709 vials of levothyroxine 200 mcg, a thyroid medication, with a ceiling value of $1,422.01. The contract has an ultimate completion date of April 7, 2025 and was awarded on April 4, 2025. It is a firm fixed price contract with no set-aside designation, indicating open...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) for the supply of 4,566,076 vials of 500 mcg Levothyroxine, a thyroid medication. The contract is a firm-fixed price arrangement with a ceiling value of $6,825.18 and an ultimate completion date of October 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Levothyroxine Sodium, a thyroid hormone replacement medication, on September 12, 2025. This firm fixed-price delivery order, valued at $1,345.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was made on a...
- This federal contract award is for the delivery of Levothyroxine 150mcg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,484.01, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $348.21 to Amerisourcebergen Drug Corp for the supply of 4561783733 levothyroxine 25 mcg capsules. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for levothyroxine supports the Agency's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Synthroid 50 mcg tablets. The $4,962.61 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order, valued at $9,454.63, is scheduled for completion by October 3, 2025, with fulfillment based at the contractor's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQAT5Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,304.88, is for the delivery of 4,563,918,234 units of the prescription drug Levothyroxine 150 mcg tablets to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/11/24 |